CXCL12 and cancer: Pseudo-time analysis suggested that CAFs with high ALDOA and CXCL12 expression represent terminal subtypes differentiated from normal fibroblasts (Figure 5C), indicating that during the malignant progression of cancer, normal fibroblasts transform into activated cancer-associated fibroblasts.